💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$3.7T
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 1/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $749.60B | $833.49 | 2.56% |
| JNJ | Johnson & Johnson | $459.32B | $190.72 | 0.19% |
| ABBV | AbbVie Inc. | $407.19B | $230.50 | 0.08% |
| MRK | Merck & Co., Inc. | $214.78B | $85.99 | 1.73% |
| TMO | Thermo Fisher Scientific Inc. | $198.17B | $524.80 | 1.85% |
| AMGN | Amgen Inc. | $156.19B | $290.13 | 1.79% |
| GILD | Gilead Sciences, Inc. | $145.40B | $117.18 | 0.38% |
| PFE | Pfizer Inc. | $140.89B | $24.78 | 1.82% |
| VRTX | Vertex Pharmaceuticals Incorporated | $104.55B | $407.79 | 1.70% |
| CVS | CVS Health Corporation | $98.80B | $77.90 | 1.51% |
| MCK | McKesson Corporation | $94.97B | $763.55 | 0.74% |
| BMY | Bristol-Myers Squibb Company | $89.48B | $43.96 | 1.61% |
| ZTS | Zoetis Inc. | $62.54B | $141.11 | 1.59% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $60.36B | $460.46 | 0.77% |
| REGN | Regeneron Pharmaceuticals, Inc. | $58.82B | $564.63 | 0.92% |
| VEEV | Veeva Systems Inc. | $46.97B | $286.59 | 3.98% |
| CAH | Cardinal Health, Inc. | $37.46B | $156.88 | 0.21% |
| INSM | Insmed Incorporated | $34.31B | $162.33 | 1.26% |
| STE | STERIS plc | $23.23B | $235.83 | 1.50% |
| BIIB | Biogen Inc. | $21.49B | $146.57 | 2.03% |
| UTHR | United Therapeutics Corporation | $19.90B | $440.00 | 1.21% |
| WST | West Pharmaceutical Services, Inc. | $18.82B | $261.77 | 0.69% |
| INCY | Incyte Corporation | $16.36B | $83.80 | 1.12% |
| MEDP | Medpace Holdings, Inc. | $14.08B | $501.22 | 3.37% |
| NBIX | Neurocrine Biosciences, Inc. | $13.55B | $136.63 | 1.33% |
| HIMS | Hims & Hers Health, Inc. | $11.74B | $53.95 | 7.38% |
| VTRS | Viatris Inc. | $11.36B | $9.74 | 2.50% |
| BAX | Baxter International Inc. | $11.27B | $21.95 | 2.49% |
| IONS | Ionis Pharmaceuticals, Inc. | $11.15B | $69.97 | 0.43% |
| BBIO | BridgeBio Pharma, Inc. | $10.61B | $55.49 | 1.28% |
| MRNA | Moderna, Inc. | $10.44B | $26.83 | 2.54% |
| WBA | Walgreens Boots Alliance, Inc. | $10.37B | $11.98 | 0.50% |
| EXEL | Exelixis, Inc. | $10.27B | $38.15 | 1.09% |
| BMRN | BioMarin Pharmaceutical Inc. | $10.05B | $52.32 | 2.84% |
| ELAN | Elanco Animal Health Incorporated | $9.82B | $19.76 | 1.54% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $9.58B | $429.60 | 0.30% |
| RVMD | Revolution Medicines, Inc. | $9.02B | $48.24 | 1.31% |
| BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
| RGEN | Repligen Corporation | $8.17B | $145.24 | 2.40% |
| CORT | Corcept Therapeutics Incorporated | $7.79B | $73.96 | 16.30% |
| HALO | Halozyme Therapeutics, Inc. | $7.50B | $64.10 | 1.55% |
| CYTK | Cytokinetics, Incorporated | $7.18B | $60.04 | 0.45% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $6.70B | $100.82 | 0.61% |
| RNA | Avidity Biosciences, Inc. | $6.40B | $49.77 | 1.97% |
| NUVL | Nuvalent, Inc. | $6.35B | $88.10 | 0.11% |
| AXSM | Axsome Therapeutics, Inc. | $6.07B | $121.71 | 0.66% |
| PCVX | Vaxcyte, Inc. | $5.67B | $43.70 | 4.07% |
| PTGX | Protagonist Therapeutics, Inc. | $5.41B | $87.00 | 29.77% |
| TGTX | TG Therapeutics, Inc. | $5.36B | $33.76 | 3.46% |
| PTCT | PTC Therapeutics, Inc. | $5.26B | $66.23 | 0.33% |
| KRYS | Krystal Biotech, Inc. | $5.25B | $181.47 | 3.86% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $4.90B | $35.41 | 1.80% |
| ACLX | Arcellx, Inc. | $4.81B | $86.80 | 1.80% |
| GKOS | Glaukos Corporation | $4.73B | $82.56 | 5.13% |
| OPCH | Option Care Health, Inc. | $4.33B | $26.71 | 0.34% |
| AKRO | Akero Therapeutics, Inc. | $4.31B | $53.88 | 0.37% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $4.23B | $44.93 | 1.81% |
| KYMR | Kymera Therapeutics, Inc. | $4.09B | $57.21 | 0.33% |
| SRRK | Scholar Rock Holding Corporation | $3.79B | $39.46 | 3.73% |
| VKTX | Viking Therapeutics, Inc. | $3.77B | $33.56 | 4.06% |
| MIRM | Mirum Pharmaceuticals, Inc. | $3.65B | $72.71 | 1.50% |
| LNTH | Lantheus Holdings, Inc. | $3.64B | $53.54 | 2.20% |
| SWTX | SpringWorks Therapeutics, Inc. | $3.54B | $46.99 | 0.02% |
| WGS | GeneDx Holdings Corp. | $3.50B | $121.72 | 4.01% |
| LGND | Ligand Pharmaceuticals Incorporated | $3.48B | $177.73 | 2.52% |
| ADMA | ADMA Biologics, Inc. | $3.47B | $14.54 | 1.36% |
| SLNO | Soleno Therapeutics, Inc. | $3.39B | $63.76 | 2.75% |
| ACAD | ACADIA Pharmaceuticals Inc. | $3.38B | $20.06 | 2.76% |
| CGON | CG Oncology, Inc. Common stock | $3.30B | $43.25 | 2.72% |
| APLS | Apellis Pharmaceuticals, Inc. | $3.17B | $25.12 | 2.37% |
| AMRX | Amneal Pharmaceuticals, Inc. | $3.13B | $9.97 | 3.06% |
| APGE | Apogee Therapeutics, Inc. | $3.07B | $52.47 | 1.39% |
| RARE | Ultragenyx Pharmaceutical Inc. | $3.03B | $31.45 | 0.66% |
| PBH | Prestige Consumer Healthcare Inc. | $3.00B | $61.00 | 2.85% |
| IMVT | Immunovant, Inc. | $2.97B | $17.03 | 2.57% |
| INDV | Indivior PLC | $2.97B | $23.78 | 1.53% |
| TARS | Tarsus Pharmaceuticals, Inc. | $2.96B | $70.14 | 0.34% |
| LEGN | Legend Biotech Corporation | $2.91B | $31.70 | 1.61% |
| ICUI | ICU Medical, Inc. | $2.82B | $114.13 | 2.36% |
| MLYS | Mineralys Therapeutics, Inc. | $2.80B | $42.16 | 7.03% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.75B | $49.00 | 1.03% |
| VCYT | Veracyte, Inc. | $2.74B | $34.80 | 0.37% |
| WRBY | Warby Parker Inc. | $2.72B | $22.26 | 6.23% |
| BEAM | Beam Therapeutics Inc. | $2.66B | $26.32 | 5.56% |
| NTLA | Intellia Therapeutics, Inc. | $2.63B | $24.52 | 3.69% |
| BLTE | Belite Bio, Inc | $2.58B | $79.28 | 0.99% |
| FOLD | Amicus Therapeutics, Inc. | $2.56B | $8.30 | 0.36% |
| OGN | Organon & Co. | $2.50B | $9.60 | 3.23% |
| CPRX | Catalyst Pharmaceuticals, Inc. | $2.49B | $20.36 | 2.21% |
| IRON | Disc Medicine, Inc. | $2.43B | $69.90 | 1.20% |
| ARQT | Arcutis Biotherapeutics, Inc. | $2.40B | $20.05 | 3.19% |
| XRAY | DENTSPLY SIRONA Inc. | $2.36B | $11.83 | 3.19% |
| AGIO | Agios Pharmaceuticals, Inc. | $2.36B | $40.61 | 4.29% |
| IDYA | IDEAYA Biosciences, Inc. | $2.30B | $26.24 | 2.05% |
| CURLF | Curaleaf Holdings, Inc. | $2.29B | $3.00 | 9.37% |
| RXRX | Recursion Pharmaceuticals, Inc. | $2.29B | $5.32 | 9.98% |
| COGT | Cogent Biosciences, Inc. | $2.27B | $16.27 | 0.49% |
| DNLI | Denali Therapeutics Inc. | $2.25B | $15.37 | 4.95% |
| TVTX | Travere Therapeutics, Inc. | $2.24B | $25.16 | 3.49% |
| IBRX | ImmunityBio, Inc. | $2.23B | $2.36 | 3.28% |